Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CLYM US Equity

Climb Bio, Inc.Health Care · Pharmaceutical Preparations · CIK 1768446 · FY ends Dec 31
$17.39
-0.05 (-0.29%)
USD · as of 2026-08-18 · marketstack
2 8-K filings · 1 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by MPM BioImpact LLCsec.gov ↗
2026-08-148-K 8.01Other eventssec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-0813GSchedule 13G filed — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-07-0713D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-07

Every row is a filed document, checked against its EDGAR index.